Literature DB >> 33524116

Associations of Height With the Risks of Colorectal and Endometrial Cancer in Persons With Lynch Syndrome.

Jesca G M Brouwer, Polly A Newcomb, Tanya M Bisseling, Jane C Figueiredo, John L Hopper, Mark A Jenkins, Jan J Koornstra, Noralane M Lindor, Hans F A Vasen, Aung K Win, Ellen Kampman, Fränzel J B van Duijnhoven.   

Abstract

People with Lynch syndrome (LS), who carry a pathogenic mutation in a DNA mismatch repair gene, have increased risks of colorectal cancer (CRC) and endometrial cancer (EC). A high reported variability in cancer risk suggests the existence of factors that modify cancer risk for persons with LS. We aimed to investigate the associations between height and CRC and EC risk for persons with LS using data from 2 large studies. Information on 1,115 men and 1,553 women with LS from the Colon Cancer Family Registry (1998-2007) and the GEOLynch Cohort Study (2006-2017) was harmonized. We used weighted Cox proportional hazards regression models with age on the time axis to estimate adjusted hazard ratios and 95% confidence intervals for each 5-cm increment in self-reported height. CRC was diagnosed in 947 persons during 65,369 person-years of observation, and 171 women were diagnosed with EC during 39,227 person-years. Height was not associated with CRC for either men (per 5-cm increment, hazard ratio (HR) = 1.00, 95% confidence interval (CI): 0.91, 1.11) or women (per 5-cm increment, HR = 1.01, 95% CI: 0.92, 1.11), nor was height associated with EC (per 5-cm increment, HR = 1.08, 95% CI: 0.94, 1.24). Hence, we observed no evidence for an association of height with either CRC or EC among persons with LS.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Lynch syndrome; body height; colorectal cancer; endometrial cancer; hereditary cancer; mismatch repair; weighted cohort

Mesh:

Year:  2021        PMID: 33524116      PMCID: PMC8210745          DOI: 10.1093/aje/kwaa175

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 3.  Normal pubertal development: part II: clinical aspects of puberty.

Authors:  Brian Bordini; Robert L Rosenfield
Journal:  Pediatr Rev       Date:  2011-07

Review 4.  Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  D Aune; D A Navarro Rosenblatt; D S M Chan; S Vingeliene; L Abar; A R Vieira; D C Greenwood; E V Bandera; T Norat
Journal:  Ann Oncol       Date:  2015-03-19       Impact factor: 32.976

5.  Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.

Authors:  Akke Botma; Fokko M Nagengast; Marieke G M Braem; Jan C M Hendriks; Jan H Kleibeuker; Hans F A Vasen; Ellen Kampman
Journal:  J Clin Oncol       Date:  2010-08-23       Impact factor: 44.544

6.  Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

Authors:  A Gylling; W M Abdel-Rahman; M Juhola; K Nuorva; E Hautala; H J Järvinen; J-P Mecklin; M Aarnio; P Peltomäki
Journal:  Gut       Date:  2007-01-31       Impact factor: 23.059

7.  Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.

Authors:  Zohreh Ketabi; Katarina Bartuma; Inge Bernstein; Susanne Malander; Henrik Grönberg; Erik Björck; Susanne Holck; Mef Nilbert
Journal:  Gynecol Oncol       Date:  2011-03-09       Impact factor: 5.482

8.  Risks of less common cancers in proven mutation carriers with lynch syndrome.

Authors:  Christoph Engel; Markus Loeffler; Verena Steinke; Nils Rahner; Elke Holinski-Feder; Wolfgang Dietmaier; Hans K Schackert; Heike Goergens; Magnus von Knebel Doeberitz; Timm O Goecke; Wolff Schmiegel; Reinhard Buettner; Gabriela Moeslein; Tom G W Letteboer; Encarna Gómez García; Frederik J Hes; Nicoline Hoogerbrugge; Fred H Menko; Theo A M van Os; Rolf H Sijmons; Anja Wagner; Irma Kluijt; Peter Propping; Hans F A Vasen
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

Review 9.  Cancer risk in Lynch Syndrome.

Authors:  Emma Barrow; James Hill; D Gareth Evans
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 10.  Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention.

Authors:  Dora Colussi; Giovanni Brandi; Franco Bazzoli; Luigi Ricciardiello
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.